The latest data from the phase 1 trial are encouraging,” said the study's lead author.
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
A new study from Karolinska Institutet has found that people with chronic kidney disease (CKD) are significantly more likely ...